Report Detail
Global Antibody-drug Conjugates Market Growth 2019-2024
- RnM3040336 |
- 28 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Takeda ranks the first in terms of revenue share in Global market of Antibody Drug Conjugate, occupies 54.17% of market share in 2016; While, Roche, with a market share of 35.11%, comes the second; The other companies consist of approximately 10.72% of the global market in 2016.
According to this study, over the next five years the Antibody-drug Conjugates market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody-drug Conjugates business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by product type, application, key manufacturers and key regions and countries.
This study considers the Antibody-drug Conjugates value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Adcetris
Kadcyla
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Lymphoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ImmunoGen
Seattle Genetics
Roche
Takeda
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antibody-drug Conjugates consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antibody-drug Conjugates market by identifying its various subsegments.
Focuses on the key global Antibody-drug Conjugates manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibody-drug Conjugates with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antibody-drug Conjugates submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Antibody-drug Conjugates Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Antibody-drug Conjugates Consumption 2014-2024
- 2.1.2 Antibody-drug Conjugates Consumption CAGR by Region
- 2.2 Antibody-drug Conjugates Segment by Type
- 2.2.1 Adcetris
- 2.2.2 Kadcyla
- 2.3 Antibody-drug Conjugates Consumption by Type
- 2.3.1 Global Antibody-drug Conjugates Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2014-2019)
- 2.4 Antibody-drug Conjugates Segment by Application
- 2.4.1 Breast Cancer
- 2.4.2 Lymphoma
- 2.5 Antibody-drug Conjugates Consumption by Application
- 2.5.1 Global Antibody-drug Conjugates Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Antibody-drug Conjugates Value and Market Share by Application (2014-2019)
- 2.5.3 Global Antibody-drug Conjugates Sale Price by Application (2014-2019)
3 Global Antibody-drug Conjugates by Players
- 3.1 Global Antibody-drug Conjugates Sales Market Share by Players
- 3.1.1 Global Antibody-drug Conjugates Sales by Players (2017-2019)
- 3.1.2 Global Antibody-drug Conjugates Sales Market Share by Players (2017-2019)
- 3.2 Global Antibody-drug Conjugates Revenue Market Share by Players
- 3.2.1 Global Antibody-drug Conjugates Revenue by Players (2017-2019)
- 3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Players (2017-2019)
- 3.3 Global Antibody-drug Conjugates Sale Price by Players
- 3.4 Global Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Antibody-drug Conjugates Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Antibody-drug Conjugates by Regions
- 4.1 Antibody-drug Conjugates by Regions
- 4.1.1 Global Antibody-drug Conjugates Consumption by Regions
- 4.1.2 Global Antibody-drug Conjugates Value by Regions
- 4.2 Americas Antibody-drug Conjugates Consumption Growth
- 4.3 APAC Antibody-drug Conjugates Consumption Growth
- 4.4 Europe Antibody-drug Conjugates Consumption Growth
- 4.5 Middle East & Africa Antibody-drug Conjugates Consumption Growth
5 Americas
- 5.1 Americas Antibody-drug Conjugates Consumption by Countries
- 5.1.1 Americas Antibody-drug Conjugates Consumption by Countries (2014-2019)
- 5.1.2 Americas Antibody-drug Conjugates Value by Countries (2014-2019)
- 5.2 Americas Antibody-drug Conjugates Consumption by Type
- 5.3 Americas Antibody-drug Conjugates Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Antibody-drug Conjugates Consumption by Countries
- 6.1.1 APAC Antibody-drug Conjugates Consumption by Countries (2014-2019)
- 6.1.2 APAC Antibody-drug Conjugates Value by Countries (2014-2019)
- 6.2 APAC Antibody-drug Conjugates Consumption by Type
- 6.3 APAC Antibody-drug Conjugates Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Antibody-drug Conjugates by Countries
- 7.1.1 Europe Antibody-drug Conjugates Consumption by Countries (2014-2019)
- 7.1.2 Europe Antibody-drug Conjugates Value by Countries (2014-2019)
- 7.2 Europe Antibody-drug Conjugates Consumption by Type
- 7.3 Europe Antibody-drug Conjugates Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Antibody-drug Conjugates by Countries
- 8.1.1 Middle East & Africa Antibody-drug Conjugates Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Antibody-drug Conjugates Value by Countries (2014-2019)
- 8.2 Middle East & Africa Antibody-drug Conjugates Consumption by Type
- 8.3 Middle East & Africa Antibody-drug Conjugates Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Antibody-drug Conjugates Distributors
- 10.3 Antibody-drug Conjugates Customer
11 Global Antibody-drug Conjugates Market Forecast
- 11.1 Global Antibody-drug Conjugates Consumption Forecast (2019-2024)
- 11.2 Global Antibody-drug Conjugates Forecast by Regions
- 11.2.1 Global Antibody-drug Conjugates Forecast by Regions (2019-2024)
- 11.2.2 Global Antibody-drug Conjugates Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Antibody-drug Conjugates Forecast by Type
- 11.8 Global Antibody-drug Conjugates Forecast by Application
12 Key Players Analysis
- 12.1 ImmunoGen
- 12.1.1 Company Details
- 12.1.2 Antibody-drug Conjugates Product Offered
- 12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 ImmunoGen News
- 12.2 Seattle Genetics
- 12.2.1 Company Details
- 12.2.2 Antibody-drug Conjugates Product Offered
- 12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Seattle Genetics News
- 12.3 Roche
- 12.3.1 Company Details
- 12.3.2 Antibody-drug Conjugates Product Offered
- 12.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Roche News
- 12.4 Takeda
- 12.4.1 Company Details
- 12.4.2 Antibody-drug Conjugates Product Offered
- 12.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Takeda News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Antibody-drug Conjugates . Industry analysis & Market Report on Antibody-drug Conjugates is a syndicated market report, published as Global Antibody-drug Conjugates Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Antibody-drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
